Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Shanghai Boxun Medical Biological Instrument has a current ratio of 4.60. It indicates the company may not be efficiently using its current assets or its short-term financing facilities. This may also indicate problems in working capital management.
BJSE:920504's Current Ratio is ranked better than 75.35% of 852
companies
in the Medical Devices & Instruments industry
Industry Median: 2.49
vs BJSE:920504: 4.60
Shanghai Boxun Medical Biological Instrument (BJSE:920504) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Shanghai Boxun Medical Biological Instrument Current Ratio Related Terms
Shanghai Boxun Medical Biological Instrument Current Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Boxun Medical Biological Instrument Current Ratio Chart
Shanghai Boxun Medical Biological Instrument Annual Data
BJSE:920504 vs ISRG, BDX, MDLN: Current Ratio Comparison
For the Medical Instruments & Supplies subindustry, Shanghai Boxun Medical Biological Instrument's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai Boxun Medical Biological Instrument Current Ratio vs Medical Devices & Instruments Industry
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Boxun Medical Biological Instrument (BJSE:920504) has a Current Ratio of 4.60 as of Mar. 2026. This is 73% above median its historical median of 2.66. Over the past decade, Shanghai Boxun Medical Biological Instrument's Current Ratio has ranged from 1.70 to 5.29. According to the industry distribution chart, Shanghai Boxun Medical Biological Instrument ranks #210 out of 852 companies in the Medical Devices & Instruments industry, placing it in the top 24.6%.
Is Shanghai Boxun Medical Biological Instrument's Current Ratio too high?
Shanghai Boxun Medical Biological Instrument's current Current Ratio of 4.60 is 73% above median its 10-year median of 2.66. Over the past 10 years, this metric has ranged from a low of 1.70 to a high of 5.29. The Medical Devices & Instruments industry median Current Ratio is 2.49. Shanghai Boxun Medical Biological Instrument's value of 4.60 is 84.7% above this industry median. Based on the distribution chart, Shanghai Boxun Medical Biological Instrument ranks #210 out of 852 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Shanghai Boxun Medical Biological Instrument has a GF Score™ of 69/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Boxun Medical Biological Instrument's Current Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Shanghai Boxun Medical Biological Instrument ranks #210 out of 852 companies for Current Ratio. This places Shanghai Boxun Medical Biological Instrument in the top 25% of its industry — outperforming the majority of peers. The industry median Current Ratio is 2.49. Shanghai Boxun Medical Biological Instrument's value of 4.60 is 84.7% above this benchmark. Historically, Shanghai Boxun Medical Biological Instrument's own Current Ratio has ranged from 1.70 to 5.29 over the past decade. While the company's 10-year median is 2.66 vs. the industry median of 2.49, Shanghai Boxun Medical Biological Instrument has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Medical Devices & Instruments company?
The median Current Ratio among Medical Devices & Instruments companies is 2.49, based on 852 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghai Boxun Medical Biological Instrument's current Current Ratio of 4.60 is 84.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median Current Ratio is 2.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai Boxun Medical Biological Instrument's current Current Ratio is 4.60, which is 73% above median its own 10-year median of 2.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Boxun Medical Biological Instrument stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Boxun Medical Biological Instrument (BJSE:920504) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥19.47, compared to a current price of ¥17.11 — trading 12.1% below its estimated fair value. The current Current Ratio is 4.60, which is 73% above median its 10-year median of 2.66 and 84.7% above the Medical Devices & Instruments industry median of 2.49. Shanghai Boxun Medical Biological Instrument's overall GF Score™ is 69/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Shanghai Boxun Medical Biological Instrument (BJSE:920504), the current Current Ratio is 4.60 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai Boxun Medical Biological Instrument (BJSE:920504) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai Boxun Medical Biological Instrument stock appears to be undervalued.
The current stock price of ¥17.11 is trading 12.1% below its estimated GF Value™ of ¥19.47.
GuruFocus considers Shanghai Boxun Medical Biological Instrument to be Modestly Undervalued.
Key valuation signals for BJSE:920504:
Current Ratio: 4.60 (73% above median its 10-year median of 2.66)
GF Value™: ¥19.47 vs. price of ¥17.11 (12.1% below fair value)
Industry Position: 84.7% above the Medical Devices & Instruments median (#210 of 852)
No single metric tells the full story. See the BJSE:920504 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shanghai Boxun Medical Biological Instrument Corp is engaged in Research and development, production, sales, and service of laboratory equipment and life science instruments. The company's main products are temperature and humidity control series products, high-pressure sterilization series products, and purification safety series products, etc.
69GF Score
Get the complete analysis for BJSE:920504
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BJSE:920504 has been successfully added to your 
